Increase prescribing efficiency
Start with the drug and dose the patient's genotype supports, rather than titrating toward it.
Genomic context for
prescribing decisions.
Medication Response™ analyzes how a patient's genetics affect their response to medication by uncovering pharmacogenomic (PGx) variants and alleles, helping providers optimize treatment, reduce adverse reactions, and improve outcomes.
70+
medications covered
90+
PGx variants and alleles analyzed
5–6 weeks
turnaround time from samples received
Blood or buccal
sample types accepted
What Medication Response does
Medication Response analyzes how a patient's genetics affect their response to medication by uncovering pharmacogenomic (PGx) variants and alleles, helping providers optimize treatment, reduce adverse reactions, and improve outcomes. Results pair each covered drug with the clinical guideline that applies to that patient's metabolizer status.
Because it runs on the genome, the same sample can be re-queried when a new prescription comes up — no repeat draw, no repeat wait.
Reduce trial and error
One result informs every future prescription among the covered medications, for the life of the patient.
Reduce side effects and major adverse events
Identify poor and ultrarapid metabolizers before a first dose rather than after a reaction.
What it detects
PGx variants linked to 70+ medications across 11 disease areas
70+
medications covered across these areas
- Behavioral health
- Cancer
- Cardiology
- Gastroenterology
- Infectious disease
- Neurology
- Pain management
- Reproductive and sexual health
- Transplant
- Urology
- Other — eczema, hyperuricemia, nausea
Choose a panel
Two ways to order Medication Response
Both test options analyze the same 15 pharmacogenes linked to 70+ medications. The difference is sequencing method, breadth of coverage, and variants reported.
Atlas Plus
Leverages whole-genome sequencing for comprehensive insights across coding and non-coding regions.
Test code
See what medications and conditions are includedMedication ResponsePR31004
Atlas Select
Uses high-coverage exome plus low-coverage whole-genome sequencing — a cost-effective option for preventative health decisions.
Test code
See what medications and conditions are includedMedication ResponsePR32005
Interpreting results
A report built to guide prescribing decisions
Each report includes 15 pharmacogenes, with findings presented alongside relevant published clinical guidelines to give providers pharmacogenomic context at the point of care.
A Clinical Guidelines Supplement accompanies every report, summarizing published drug-gene guidance specific to the patient's results to aid interpretation and clinical action.
Genetic counseling is available
MyOme offers genetic counseling for a more comprehensive assessment and personalized medication management.
Representative report page — not an actual patient result.
Test logistics
Eligibility, Turnaround Times, and Sample Types
Who it's for
Patients who are considering treatment for one of the covered conditions, or who want to take a proactive approach to guide potential medication choices in the future — helping to inform safer, more effective drug selection and dosing decisions.
Turnaround times
From samples received, most results are delivered in 5 to 6 weeks. Follow-up testing or re-requisitions for existing MyOme patients are typically completed in under 2 weeks, often within a few days.
Sample Types Accepted
- Blood
- Buccal (cheek swab)
Turnaround times are estimates and begin once samples are processed at MyOme. They may be extended in cases outside MyOme's control, including delays related to confirmation testing or other unforeseen circumstances.
Important considerations
Genetics is one input among many
Current medications, age, weight, kidney and liver function, and diet all influence response to treatment.
Genes and variants outside the panel can affect drug metabolism and are not reflected in the result.
Results should be interpreted in the context of the patient's complete medical profile by a clinician.
Learn more
Medication Response Resources
Genomic risk, mapped. Lifelong health, guided.
We're here at every step — from ordering and sample collection to interpreting results with your patients.